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Abstract 
Introduction:  The prevalence of type 2 diabetes mellitus (DM) is rapidly increasing and 
recent estimates rank type 2 DM as the 7th leading cause of death in the United States. 
Although some evidence suggests that consuming a vegetarian diet may lead to better glycemic 
control and improved metabolic outcomes compared with a conventional hypocaloric diet 
among persons with type 2 DM, there is uncertainty regarding the magnitude of benefit and the 
specific outcomes that show benefit.  Medical costs associated with diabetes, overweight, heart 
disease, lipid disorders and hypertension are a significant cost to the healthcare system and 
employers.  The need for reductions in these illnesses is driven by both medical and economic 
concerns and requires a targeted approach in both the patient-care and workplace settings. 
Objective: To conduct a systematic review of clinical trials evaluating the benefit of vegan and 
vegetarian diets for improving glycemic control and other metabolic outcomes in type 2 DM 
Methods:  Data source: PubMed, EMBASE, Cochrane and the Clinical Trails databases were 
searched for trials published in the English language in the last ten years through April 4, 2018. 
The following criteria were used for study inclusion: (1) studies enrolling adults (18 years or 
older); (2) vegan or vegetarian diet as the intervention; and (3) participants had a previous 
diagnosis of type 2 DM.  Main outcome measures were HbA1c, body weight and LDL levels. 
Critical appraisal and abstraction of relevant data from studies was performed by one author.  
Results: Eight studies met inclusion criteria (785 total participants, mean age 53 years).  Vegan 
and vegetarian diets were shown to be associated with a significant reduction in HbA1c, body 
weight, and LDL levels.  Consumption of a vegan or vegetarian diet yielded a decrease in 
HbA1c  of -0.40% to -0.65% in the intervention arm of the four best studies.   These same 
studies had an HbA1c change in the control arm of -0.08% to 0.21%.   The difference between 
intervention and control groups mean change in HbA1c was reported with statistical significance 
in five studies with a range of -1.5% to -0.7 %.  In the three of the studies reporting on BMI, 
differences between groups in mean changes from baseline were all statistically significant and 
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ranged from  -1.0 kg/m2 to -3.9 kg/m2.   In four of the studies reporting on weight change, 
differences between groups in mean changes from baseline were all statistically significant and 
ranged from -2.8 kg to -10.6 kg.  In four of the studies reporting on LDL, differences between 
groups in mean changes from baseline were all statistically significant and ranged from -7.2 
mg/dL to -0.54 mg/dL. 
Conclusion:   This systematic review supports the evidence from clinical trials that vegan and 
vegetarian diets reduce HbA1c levels and results in weight loss in adults with type 2 diabetes.  
The health benefits of introducing a vegan or vegetarian diet program, at home or in a corporate 
setting, can lead to improving the management of type 2 DM in adults, and reducing morbidity 
and mortality of type 2 DM. 
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Introduction 
Diabetes mellitus, type2,  is one of the fastest growing chronic diseases, with 
approximately 422 million cases worldwide in 2014.16 In 2015, 30.3 million Americans (9.4% of 
the US population) were estimated to have diabetes; the estimated prevalence is higher among 
adults over 65 years of age (25.2%).15   Diabetes accounts for $176 billion of direct medical 
costs in the US, including annual per capita costs of $7900, a number 2.3 times higher than 
costs for adults without diabetes.  In 2015, type 2 DM was estimated to be the 7th leading cause 
of death in the United States.16  The financial toll of type 2 DM is carried by the healthcare 
system and employers in the United States.  An estimated 25–30% of medical costs incurred by 
employers are attributable to excess risk associated with specific factors, including diabetes, 
overweight, heart disease, lipid disorders and hypertension.9, 26 The need for reductions in these 
illnesses is driven by both medical and economic concerns. 
The burden of type 2 DM is growing, and globally, the number of people with diabetes is 
expected to exceed 430 million by 2030.  Patients with diabetes are more than twice as likely to 
die from vascular causes, such as cardiovascular disease (CVD) and chronic kidney disease 
(CKD), as those without diabetes.  CVD alone accounts for approximately 60% of the life years 
lost from diabetes.  Diabetes is the leading cause of CKD in the United States with the Medicare 
expenditure on the US end-stage renal disease ESRD program alone reaching 33 billion dollars 
in 2010.32  Among older adults, diabetes is associated with an increased risk of mortality, 
reduced functional status, and increased risk of institutionalization.14  
The American Diabetes Association has made several recommendations regarding the 
medical nutrition therapy of diabetes, all of which emphasize the importance of minimizing 
macrovascular and microvascular complications in people with diabetes.31 Diet and lifestyle 
interventions have been shown to be effective tools for type 2 DM prevention and 
management.14 Dietary advice is one of the cornerstones in the management of type 2 DM, 
however, there is limited evidence on the optimal approaches to glycemic control and weight 
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loss in type 2 diabetics.  In particular, vegan and vegetarian diets, plant-based diets that 
emphasize legumes, whole grains, vegetables, fruits, nuts, and seeds and discourage all animal 
products, may be particularly effective in preventing type 2 DM and lowering rates of obesity, 
hypertension, hyperlipidemia, cardiovascular mortality, and cancer.14  Multiple potential 
mechanisms underlie the benefits of a plant-based diet in decreasing insulin resistance; 
including promotion of a healthy body weight; increases in fiber and phytonutrients; food-
microbiome interactions; and decreases in saturated fat; advanced glycation end-products; 
nitrosamines; and heme iron.14   
Although some evidence suggests that consuming  a vegetarian diet may lead to a 
greater weight loss and greater reduction in fasting plasma glucose, hemoglobin A1c, plasma 
lipids, and hypoglycemic medication than a conventional hypocaloric diet in subjects with type 2 
DM, there is uncertainty regarding the magnitude of benefit and the specific outcomes that show 
benefit.4  This systematic review aims to examine the literature evaluating the health benefits of 
a vegan or vegetarian diet in the treatment of adults with DM type 2.   
Methods 
Data Sources and Searches 
In order to review recent evidence related to the benefit of vegan or vegetarian diets 
among adults with diabetes, our literature search was limited to studies published in the last ten 
years.  PubMed, EMBASE, Cochrane and the Clinical Trails databases were searched from 
April 2008 to April 2018 for English language articles. Eligible populations included adults 
previously diagnosed with DM type 2. Studies had to compare a dietary intervention focused on 
a vegan or vegetarian diet with another type of diet.  Full inclusion and exclusion criteria and 
search terms are included in Tables 1-3.  A research librarian at the University of North Carolina 
Health Sciences Library assisted in the formulation of the search strategy.  Only randomized 
control trials were retained in the search results and one author independently reviewed all titles 
and abstracts identified by the search.  In this review, the intervention of a vegan or vegetarian 
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diet included only those studies where the definition of vegan and vegetarian did not include any 
meat.  This review outlines change in several blood levels that are used to monitor the 
management of a patient with type 2 diabetes.  The outcome markers of interest included were 
body mass index (BMI), body weight, fasting glucose, hemoglobin A1c, and various lipid levels.   
Data Abstraction 
With the assistance of an experienced medical research librarian, searches in PubMed, 
EMBASE, Cochrane and Clinical Trials were completed and exported into a standardized data 
collection instrument called Covidence.  The key question’s focus was the health benefits of 
vegan or vegetarian diets on the management of type 2 DM.  Articles were abstracted by 
evaluating the study design, the time frame of the study, population, sources of bias from 
selection, measurement, confounding, outcome measure and results.  A full list of inclusion and 
exclusion criteria are listed in Table 2. 
Results 
Results of Literature Review 
Details of the literature review, including reasons for excluding articles at the full-text 
stage are shown in Figure 1.  A total of 898 unique citations were identified and screened by 
title and abstract.  After abstract review, the full-texts of 181 potentially eligible citations were 
reviewed again for eligibility.  Of these, 173 publications were excluded.  Reasons for exclusion 
at the full-text stage are shown in Figure1.  No additional studies were identified through 
ClinicalTrials.gov.   In total, 8 studies met full inclusion criteria, as shown in Figure 1.2,4,5,6,7,8,9,10 
Study Characteristics 
 
Of eight studies identified, with 785 participants, all were randomized controlled trials 
(RCTs), and one trial was a crossover design.5  All were open (non-masked) lasting at least 
eight weeks, with half of them lasting almost 6 months or more.2, 4, 9, 10  The longest trial was 74-
weeks.2  Across all included RCTs, the sample size ranged from 18 to 291 participants, with the 
average number of participants being 98.  The mean age of enrolled participants ranged from 
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44 to 59 years across all included studies.  One study reported the age range but did not report 
the mean age of the participants.7  Seven of the studies had a majority of female participants 
(ranging from 53 to 83%)2, 4, 6, 7, 8, 9, 10, and one enrolled a minority of female participants (33%).5   
The most common results obtained by the studies were hemoglobin A1c, body weight or BMI, 
and LDL studies.  Fasting glucose, blood pressure, hip and waist measurements and other lipid 
studies such as total cholesterol, HDL and triglycerides were also obtained in many of the 
studies. 
The various studies included other outcomes such as blood pressure, albumin levels, 
insulin resistance, insulin sensitivity, and lipoprotein fractions, however, for consistency and 
closer comparisons, reviews were required to have at least one of the five outcome markers of 
interest.  As shown in Table 4, five studies were conducted in the United States, one in South 
Korea, one in New Zealand and one in the Czech Republic. 
Population Characteristics  
The participants in all of the trials were 18 years or older and previously diagnosed with 
type 2 DM, with the exception of one study where patients could have one of the following 
diagnoses, type 2 diabetes, hypertension, hyperlipidemia, heart disease, in combination with 
being obese or overweight.10  Participant recruitment was discussed in seven studies. 2, 4, 6, 7, 8, 9, 
10  Advertisement in a newspaper or flier was used in five studies, two of which were within a 
corporation.4, 9  Two studies used clinicians to select participants to invite to the study.6, 8  In all 
studies, participants were willing to make dietary changes to be part of the studies.  One study 
focused on Korean participants while another focused on Latino participants who lived in 
medically underserved areas.7, 8  In the Korean study, a vegetarian diet was used, however, fish 
was also allowed.8  All studies required that the participants were not previously on a vegan or 
vegetarian diet.  Six of the studies used similar exclusion criteria for participants.2, 4, 6, 8, 9, 10  This 
exclusion list included no drug or alcohol abuse, no pregnancy or lactation, no unstable medical 
 9 
conditions, and no severe mental illness.  One study also required participants not be using 
insulin medication. 
Intervention Characteristics  
Vegan diets were the identified intervention in five studies, and the other three used a 
vegetarian diet as the intervention.  Two of the vegetarian interventions used a high fiber 
vegetarian diet.5, 10  Five studies used a low-fat plant-based diet.2, 4, 5, 9, 10  However, all of the 
intervention diets focused on legumes, whole grains, vegetables, and fruits. Two of the low fat 
vegan studies were done at corporate sites, focusing on workplace intervention with employees 
who had a BMI of 25 kg/m2 or more.4, 9  These corporate studies recruited geographically 
diverse participants from eight states across the country.  The comparator diets included three 
studies using a typical American diet including meat, three studies used a conventional diabetic 
diet, one used the 2011 recommended Korean Diabetic Association Diet, and one used a plant-
based diet with low carbohydrates and mono-unsaturated fat.   
Five of the studies allowed participants to eat as much as they desired without any 
calorie restrictions.4, 5, 7, 9, 10  Three of the studies restricted calories by 500 kcal in both 
intervention and control groups.2, 6, 8  Of these three energy restricted diets, one chose to target 
only the participants that had a BMI greater than 25 mg/kg2.2  Six studies asked participants to 
not make any changes to their exercise routines.2, 5, 6, 7, 8, 10  One study asked participants make 
no changes for the first half of a 24-week study, and then encouraged aerobic exercise for the 
second half of the study.6  Exercise was not discussed in one study.4  Vitamin B12 is a typical 
supplement in plant-based diet and was provided to participants in five of the eight studies.2, 4, 6, 
9, 10  Dietary education was provided on a scheduled and frequent basis in seven of the eight 
studies2, 4, 6, 7, 8, 9, 10, six of the studies used a dietician to meet regularly with participants as well 
as make both scheduled and unscheduled calls to participants2, 4, 6, 7, 8, 9, and five of these 
studies had participants keep a food diary for at least some portions of the study.2, 4, 6, 8, 9  One of 
the studies did not use diet education, food diaries or a dietician.5 
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Study Quality 
All eight studies used a method of randomization, however, none of the participants 
were blinded in the studies because the studies were dietary intervention trials.  The process by 
which measurements were taken and the machines used for measurements were discussed in 
detail and standardized in five of the studies. 2, 6, 8, 9, 10  Three of the studies did not give any 
detail on how measurements were performed.4, 5, 7  One study mentioned that the people doing 
the measurements were not blinded to the participant group, however, in this study the 
statistician was blinded to participant group.10  One study noted that the persons performing the 
measurements were blinded to participant group.5  The tables of characteristics within each 
study did not report any significant differences in characteristics of participants in the 
intervention and control arms.  The different studies had variability with regards to the 
intervention diet proportion of carbohydrate, protein and fat ratios.   
Baseline Data 
The baseline data for all eight studies is listed in Table 4.  Of the eight studies, five of 
the studies had very similar data and participants which made them easier to compare.2, 4, 6, 9, 10  
The remaining three studies provide good supporting information, however, have a more varied 
participant population and intervention, making it more difficult to directly compare the results.5, 7, 
8  The mean BMI of participants was 31.6 kg/m2, with one study not providing baseline BMI 
information.  In that study, the baseline average weight was 99.4 kg (219.1 lbs).4  For the five 
most similar studies, the mean baseline BMI range was 34.4 – 35 kg/m2. 2, 4, 6, 9, 10  These five 
studies also provided the average weight at baseline, and the mean weight was 98.2 kg (216.4 
lbs.) at baseline.  All eight studies reported HbA1c levels at baseline and at completion of the 
study.  The HbA1c at baseline was an average of 7.64% (range of 6.9% – 9.1%) for the seven 
studies that reported HbA1c in percent versus mmol/mol.2, 4, 5, 6, 7, 8, 9  Four of the five similar 
studies provided a baseline HbA1c range of  7.1% – 8.0%.2, 4, 6, 9  Fasting glucose at baseline 
was only reported in three studies (mean 155 mg/dL)2, 6, 8 and LDL at baseline was provided in 
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five studies.2, 4, 6, 8, 9  Four of the studies reported LDL in mg/dL (versus mmol/L) and the average 
was 105.6 mg/dL. 2, 4, 8, 9   
Outcome Data of Included Studies 
The outcome data for the eight studies are shown in Table 5 and Table 6.  Consumption 
of a vegan or vegetarian diet yielded a decrease in HbA1c  of -0.40% to -0.65% in the 
intervention arm of the four best studies.2, 4, 6, 9   These same studies had an HbA1c change in 
the control arm of -0.08% to 0.21%.2, 4, 6, 9   One study used mmol/mol to report HbA1c and 
showed a HbA1c mean difference of 5 mmol/mol.10  The difference between intervention and 
control groups mean change in HbA1c was reported with statistical significance in five studies 
with a range of -1.5% to -0.7 %.2, 7, 8, 9, 10  In the study with the longest duration, when controlling 
for medication changes, the HbA1c levels went from 0.20% to 0.41% (p=0.03) difference 
between the means, and LDL difference between the means went from -4.1 mg/dL to -10.1 
mg/dL (p=0.03).2  Fasting glucose changes from baseline were not found to be statistically 
significant and were as high as 13.2 mg/dL lower on a vegan diet compared to a conventional 
diabetic diet.8 
In the three of the studies reporting on BMI, differences between groups in mean 
changes from baseline were all statistically significant and ranged from -1.0 kg/m2 to -3.9 
kg/m2.6, 9, 10  In four of the studies reporting on weight change, differences between groups in 
mean changes from baseline were all statistically significant and ranged from -2.8 kg to -10.6 
kg.4, 6, 9, 10  The largest and longest study showed a mean BMI change from baseline of -1.6 
kg/m2 in the intervention group versus a -1.1 kg/m2 in the control group.  This same study 
showed a mean weight change from baseline of -4.4 kg in the intervention arm versus -3.0 kg in 
the control arm.  Although not shown to be statistically significant, these changes are consistent 
with the other studies and were maintained for 74 weeks.2 
Cholesterol was an outcome in all eight studies as this is an important factor in both 
diabetes treatment and morbidity and mortality of people with type 2 DM.  While total 
 12 
cholesterol, HDL and LDL were monitored in most studies, LDL was most similarly reported on 
in these studies.  In four of the studies reporting on LDL, differences between groups in mean 
changes from baseline were all statistically significant and ranged from -7.2 mg/dL to -0.54 
mg/dL.2, 5, 6, 9  The remaining three studies that reported on LDL showed differences between 
groups in mean changes from baseline in a range of -7.2 mg/dL to -1.8 mg/dL.4, 8, 10   
Five of these studies used low fat vegan or vegetarian diet as the intervention.2, 4, 5, 9, 10  
The comparator for these four studies was either a 2003 American Diabetic Association 
recommended diet or a regular meat diet.  Despite the lower fat intake in these four studies, 
there was not an obvious difference in the results from the other studies.  The two corporate 
studies, with a combined 404 participants, had almost identical baseline characteristics, both 
compared a low fat vegan diet to a meat diet, and both had statistically significant reductions in 
HbA1c and weight.4, 9  For both studies, the intervention led to a 0.7% greater reduction in 
HbA1c and a 2.8 kg and 5.3 kg greater reduction in weight.4, 9  One study that used low-fat 
vegetarian diet as the intervention had the highest weight loss and mean BMI changes from 
baseline.10  This study was also unique in that it allowed the participants to have a diagnosis of 
either type 2 diabetes, hypertension, hyperlipidemia or heart disease, in combination with being 
obese or overweight.  This study did not have any restriction on number of calories consumed.  
The focus of the intervention was on decreasing energy density of the food consumed, 
decreasing the fat intake and increasing the water and fiber intake, and, thus, increasing 
satiety.10  
Compliance 
The food diaries were used to write down what participants ate at different intervals in 
the study and this information was used to measure compliance.  The dietician would also 
interview the participants to measure compliance with the prescribed diet.  Six of the eight 
studies reported on diet compliance, using diaries, interviews, and questionnaires to assess 
compliance.  The compliance ratings were 64% on average (range, 51% - 82%).2, 4, 6, 8, 9, 10 
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Discussion 
 Across all included studies, results of this review indicate that plant-based diets improve 
the management of type 2 DM in adults.  The results reveal a pattern of improvement in 
glycemic control, weight loss, and improved lipid levels consistent with previous systematic 
reviews and meta-analyses showing statistically significant HbA1c improvements of 0.4% and 
0.9%.13, 17 
The most significant results from this review is the statistical significance in glycemic 
control and weight change; five of the eight studies showed statistical significance in improving 
HbA1c levels (-1.5% to -0.7 %).2, 7, 8, 9, 10  HbA1c levels are a strong predictor of diabetes 
sequelae and cardiovascular events and, thus, these results show a clear benefit of vegan and 
vegetarian diets in the treatment of type 2 diabetes.18  Weight loss and decrease in BMI was 
found to be statistically significant with four of 8 studies reporting weight outcomes, with as 
much at 10.6 kg greater weight loss in the intervention arm.4, 6, 9, 10  Weight loss is important 
because weight loss alone has been shown to improve glycemic control.  In addition, obesity 
alone is considered a major risk factor for type 2 diabetes and cardiovascular disease, and 
many studies suggest that weight management is the most important therapeutic tool for 
patients with type 2 diabetes.24 
A low-fat vegan diet showed statistically and clinically significant improvements in body 
weight, plasma lipids and glycemic control, even without any caloric restriction or exercise.4, 5, 7, 
9, 10  In the study with the longest duration, when controlling for medication changes, hemoglobin 
A1c and plasma lipid levels reductions were more than double in the intervention group.2  The 
low-fat vegetarian diet with no intake restrictions led to significant reductions in weight and 
BMI.10  The high fiber/high carbohydrate plant-based diet with a low glycemic load led to 
significant reductions in postprandial lipoproteins, blunted post-prandial glucose and decreased 
late post-prandial hypoglycemia.5  Post-prandial insulin decreased as a result of the decreased 
glucose levels, suggesting an improved insulin sensitivity.5  
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Dietary compliance is strongly correlated with weight loss.  In one of the studies showing 
good compliance, the difference between the two arms doubled from 0.3% to 0.6%.8  Having a 
supportive environment, health education and cooking demonstrations were found to increase 
the success and compliance.4 This is important to note for both future study designs and for 
implementation of programs in primary care and the workplace, where dietary education and 
group support could be paired with a plant based diet. 
Vegetarian and vegan diets improve glycemic control and weight loss in patients with 
type 2 diabetes by increasing fiber intake, decreasing saturated fat intake, increasing non-heme 
iron and reducing iron stores, increasing vegetable protein in place of animal protein, and 
increasing antioxidants and plant sterols.6   All eight of these studies attribute this to a higher 
consumption of high dietary fiber with a low glycemic index, leading to a lower energy density in 
the food consumed.31  The reduction in energy intake leads to weight loss, which is known to 
improve glycemic control.22   
The decreased energy density, less fat and higher fiber and water content, lead to 
increased satiety, dietary adherence and lower overall intake.  In addition, low-fat vegan diets 
increase insulin sensitivity in cells creating a thermic effect because the cells metabolize 
glucose more quickly rather than store it as body fat.  This increases the post-prandial calorie 
burn by 16% up to three hours after a meal. 27  The plant-based diet is also typically lower in 
saturated fatty acid and is associated with improvements in plasma lipids.31  A decrease in 
intramyocellular lipid concentrations and a decrease in visceral fat both lead to an increase in 
insulin sensitivity.29 
The higher dietary fiber in plant-based diets can also reduce the risk of type 2 diabetes 
by several mechanisms.  Dietary fiber may slow glucose absorption from the intestine, which 
lowers the glycemic index of carbohydrates.30  Low-fat vegan diets decrease plasma lipid levels 
because of the absence of animal fat and the lipid-lowering effect of plant-based foods. 28  In 
addition, persistent organic pollutants (POPs), mainly found in fatty animal foods, are known to 
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disturb glucose and lipid metabolism.25  Vegan diets have lower doses of POPs which may 
attribute to improvements in glycemic control as POPs are a risk factor in T2DM, poor glycemic 
control in T2DM and present an increased risk for cardiovascular diseases.8 
Strengths  
This review has several strengths.  First, the studies were all randomized and published 
within the last ten years.  Second, all of the studies were a minimum of eight weeks in duration 
which is adequate to observe meaningful changes in HbA1c.  Third, this review looks at both 
plant-based diets in a variety of conditions and geographically diverse locations without tight 
control on the diet itself.  This allows these results to be more broadly generalizable to many 
populations.  A fourth strength is that within these studies, the intervention and control arms of 
the studies had no significant heterogeneity in their characteristics. A fifth strength is the parallel 
design in all studies, in which all participants started simultaneously, allowing the investigators 
to follow participants and perform measurements at the same time.  Of note, these studies used 
diabetic participants that had long-standing diabetes and none of the studies reported any 
adverse outcomes, making this intervention little to no risk to employ. 
Limitations 
This body of literature has limitations. In terms of applicability, all enrolled a self-selected 
population and two of the studies were set in a corporate setting with relatively healthy 
employees.  These factors may bias the results towards greater improvement with the 
intervention diet as participants who self-select or who are participating in an intervention at 
their worksite may be more motivated to participate and more likely to comply with the 
intervention.  Two of the studies chose participants who were disadvantaged socioeconomically 
and medically underserved.  Results from these studies may not be generalizable to a broader 
population.  In terms of study design, there is a potential for measurement bias; investigators 
collecting data and performing analyses were generally not blinded, with the exception of one 
study.  Implementation of diet changes typically benefit from multi-disciplinary approach to 
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support the patient.  Education and dietician phone calls were more robust in the intervention 
groups and this type of addition to the intervention is also not typical of a person who may be 
embarking on a vegan or vegetarian diet outside of the study.   
The studies had some inherent design limitations, such as small sample sizes and some 
with short durations with half of the studies being only 3 months or less. Also, the participants 
were predominantly female as is commonly found in these types of studies.  It is not clear how 
that may affect the results.  Several confounders were present such as the variations in the 
interventions, some with energy restrictions and others not, some performed outside the United 
States, one allowing fish, and most not monitoring the physical activity of participants.4, 9  
Variations in the control diets were also a confounder as some were a standard meat 
diet and some a diabetic diet.  Most studies did not report if the people doing measurements, 
laboratory work or statistical analysis were blinded. Another confounder was the independent 
effect of weight change on the other measured variables of glycemic control and lipid profile. It 
is difficult to isolate the effect of weight change on these markers of cardiovascular risk.11  
These factors limit the ability to attribute improvement in outcomes directly to a plant-based diet.  
Additionally, in these studies, most participants in both groups altered medications, often 
because of clinical success (low blood glucose values) in the intervention arms, and sometimes 
because of worsening blood glucose levels in the control arm.10  This is a confounding variable 
that requires special statistical analysis.   
Plant-based diets are a great adjunctive tool for primary care practitioners in the 
management adults with type 2 DM.   While the studies in this review show relatively small 
improvements in the glycemic control, weight loss and cholesterol levels, these are relatively 
sizable considering the short durations of these studies.  Introducing plant-based diets is a less 
expensive and at lower side effect profile than medications for type 2 DM.  As noted above, 
these lifestyle changes are best implemented with dietary education support which is likely the 
most challenging aspect of implementation.  Where possible, dietary coaching and cooking 
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support would assist the success of such changes.  Supplying plant-based diets in corporate 
settings along with group dietary education and coaching is a great approach to cast a wide net, 
establishing a plant-based pattern of eating which may encourage similar changes away from 
the workplace.  
Future Studies 
To increase the applicability of these results, a good study design would include an 
intervention of a plant based diet with no calorie restriction, no exercise requirement, B12 
supplementation, dietary education and food diary requirements.  These study requirements 
would most similarly mirror someone attempting to make these diet changes and the food diary 
would allow for verification of compliance.  Further studies are needed to explore the 
relationships between specific foods and glycemic control as the studies in this review did not 
have a clear guide for the proportions of fat to carbohydrate to protein within a vegan or 
vegetarian diet.  Longer randomized controlled trials are needed to determine the long-term 
compliance and health effects of plant-based diets.  It would also be beneficial to target 
employee interventions to clarify whether interventions that encourage plant-based diets are 
effective in a workplace setting. 
Conclusions 
This systematic review supports the evidence from clinical trials that vegan and 
vegetarian diets reduce HbA1c levels and result in weight loss in type 2 diabetics.  These 
important tool for improving obesity, diabetes, and cardiovascular disease must be transferred 
to settings where people live and work. Providers, patients, and employers must be made aware 
of the benefits of nutritional therapy such as vegan and vegetarian diets. This systematic review 
demonstrates the health benefits of introducing a vegan or vegetarian diet program.  These diet 
changes can lead to improving the management of type 2 DM in adults, and the long-term 
health benefits of reducing morbidity and mortality and the burden of type 2 DM. 
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Figure 1.  PRISMA Flow Diagram:  database search (2008 – 2018) 
Showing the number of studies screened, assessed for eligibility, and included in the 
review.  
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Table 1: Key Question 
 
Key Questions  
1 Among adult patients with diabetes mellitus, type 2, do vegetarian or vegan 
diets improve the management of diabetes mellitus? 
 
 
 
Table 2: Study Inclusion and Exclusion Criteria 
 
Category Inclusion Criteria Exclusion Criteria 
Population Adults, > = 18 years old with diabetes 
mellitus type 2 
Children (< 18 years old) 
Adults with diabetes 
mellitus type 1 
Intervention Vegetarian or Vegan Diet with or without 
dietary education  
 Diets containing meat 
Comparator Compared to another type of diet No comparator  
Outcomes Fasting glucose, Hemoglobin A1c, Body 
weight, BMI, Lipid levels, management of 
diabetes mellitus type 2 
Qualitative measures only 
Measures of prevention of 
diabetes 
Timing Studies within the last 10 years Studies older than 10 
years 
Settings Inpatient or outpatient, world-wide None 
Publication 
language 
English Language other than 
English 
Admissible 
evidence 
(study 
design and 
other criteria) 
Published in full 
Original research 
Cross-sectional studies 
Clinical trials completed 
Cohort studies 
Randomized Controlled Trials 
Controlled Trials 
Studies not published in 
full 
Qualitative studies 
Results of cognitive 
interviews 
Clinical trials in progress 
Editorials 
Policy or 
Recommendation 
statements 
Case Reports 
Systematic Reviews  
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Table 3: PUBMED, EMBASE, Cochrane and Clinical Trials Search Strategy 
 
PubMed 
Search date: April 4, 2018 
#1 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes 
467 
#2 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes Mellitus 
227 
 
 
EMBASE 
Search date: April 4, 2018 
#1 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes 
790 
#2 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes Mellitus 
625 
 
Cochrane 
Search date: April 4, 2018 
#1 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes 
5 
#2 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes Mellitus 
5 
 
Clinical Trials 
Search date: April 4, 2018 
#1 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes 
5 
#2 Vegetarian* OR vegan* OR “plant-based diet” OR “plant-based dietary” OR 
“plant-based diets” OR “plant-based foods” OR “plant-based food” 
AND 
Diabetes Mellitus 
5 
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Table 4:  Designs and characteristics of studies used in systematic review. 
 
 
 
Study, year, 
reference 
Country Study 
Design 
Intervention 
diet 
Comparison 
diet 
Duration 
(weeks) 
Number 
(I/C) 
Mean 
age 
(yrs.) 
Femal
e (%) 
Mean BMI 
at 
Baseline 
(kg/m2) 
Fasting 
Glucose 
at 
Baseline 
A1c at 
Baseline 
(%) 
Weight 
at 
Baseline 
(kg) 
LDL 
at 
Baseline 
Barnard et 
al., 2009 (2) 
US RCT Low-fat 
vegan 
2003 
American 
Diabetic Diet 
74 99 (49, 
50) 
56 61 35 162 mg/dL 8 98 111 
mg/dL 
Ferdowsian 
et al., 2010 
(4) 
US RCT Low-fat 
vegan 
Meat diet 22 113 (68, 
45) 
44 83 _ _ 7.1 99.4 105.6 
mg/dL 
De Natale et 
al., 2009 (5) 
US R 
Cross-
over 
High 
fiber/High 
carbohydrate 
vegetarian 
Low 
carb/Mono-
unsaturated 
fat vegetarian 
4 + 4 18 59 33 27 _ 6.9 _ _ 
Kahleova et 
al., 2011 (6) 
Czech 
Republic 
RCT Vegan Conventional 
diabetic diet 
12 74 (37, 
37) 
56 53 35 9.5 
mmol l-1 
7.65 101 2.56 
mmol l-1 
Mishra et al., 
2013 (9) 
US RCT Low-fat 
vegan 
Meat diet 18 291 
(143, 
149) 
45 83 35 _ 7.30 96.5 108.2 
mg/dL 
Yu-Mi et al., 
2016 (8) 
South 
Korea 
RCT Vegan 2011 Korean 
Diabetic 
Association 
Diet 
12 93 (47, 
46) 
58 81 23.5 132 mg/dL 7.5 _ 97.7 
mg/dL 
Ramal et al., 
2017 (7) 
US RCT Vegetarian Conventional 
diet 
26 32 (17, 
15) 
_ 78 31 _ 9.05 _ _ 
Wright et al., 
2017 (10) 
New 
Zealand 
RCT Low-fat 
vegetarian 
Meat diet 26 65 (33, 
32) 
56 60 34.4 _ 39.5 
mmol/mol 
95.9 _ 
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Table 5:  Differences from baseline of studies used in systematic review. 
Study, year, 
reference 
Study 
Design 
Intervention 
diet 
Comparison diet BMI change 
(kg/m2) (I,C) 
Fasting Glucose 
change (mg/dL) 
(I,C) 
A1c change (%) 
(I,C) 
Weight change 
(kg) 
(I,C) 
LDL change 
(I,C) 
Barnard et al., 2009 
(2) 
RCT Low-fat vegan 2003 American 
Diabetic Diet 
-1.6, -1.1 -14.1, -6.5 -0.40, +0.01 -4.4, -3.0 -13.5, -3.4 mg/dL 
Ferdowsian et al., 
2010  (4) 
CT Low-fat vegan Meat diet _ _ -1.0, -0.2 -5.1, +0.1 -5.2 -1.4 mg/dL 
De Natale et al., 
2009 (5) 
R Cross-
over 
High fiber/High 
carbohydrate 
vegetarian 
Low carb/Mono-
unsaturated fat 
vegetarian 
_ -6.6, -- 0.0 0.0 -2.62, -0.4 mg/dL 
(P< 0.05) 
Kahleova et al., 
2011 (6) 
RCT Vegan Conventional 
diabetic diet 
-2.018, -0.98 
(P< 0.001) 
-1.49, -1.05 
(P< 0.42) 
-0.65, 0.21  
(P< 0.375) 
-6.2, -3.2  
(P< 0.001) 
-0.17, -0.14 mmol l-
1 (P< 0.05) 
Mishra et al., 2013 
(9) 
RCT Low-fat vegan Meat diet -1.04, 0.01 _ -0.60, -0.08 -2.9, -0.06 -8.1, -0.9 mg/dL 
Yu-Mi et al., 2016 
(8) 
RCT Vegan 2011 Korean 
Diabetic 
Association Diet 
-0.5, -0.1 
(P< 0.092) 
-13.2, 0.0 
(P< 0.146) 
-0.5, -0.2 
(P< 0.017) 
_ -2.8, -1.0 mg/dL 
(P< 0.732) 
Ramal et al., 2017 
(7) 
RCT Vegetarian Conventional diet +0.02, -0.16 
(P< 0.478) 
 
_ -1.24, -0.07 
(P< 0.002) 
_ _ 
Wright et al., 2017 
(10) 
RCT Low-fat 
vegetarian 
Meat diet -4.4, -0.5 _ -3, +2 
mmol/mol 
-12.1, -1.6 -.08, -0.04 
mmol l-1 
26 
 
 
Table  5:  Mean differences in selected studies used in systematic review. 
 
Study, year, 
reference 
Study 
Design 
Intervention 
diet 
Comparison 
diet 
BMI change 
(kg/m2) 
Fasting Glucose 
change (mg/dL) 
A1c 
change (%) 
Weight 
change 
(kg) 
LDL change 
(mg/dL) 
                   Between group difference in change score, mean (95% CI) 
Barnard et al., 2009 
(2) 
RCT Low-fat vegan 2003 American 
Diabetic Diet 
-0.5 
(P 0.25) 
-7.6 
(P 0.44) 
-0.41 
(P 0.03) 
-1.4 
(P 0.25) 
-1.1 
(P 0.03) 
Ferdowsian et al., 
2010 (4) 
RCT Low-fat vegan Meat diet _ _ -0.7 -5.3 
(P<0.0001) 
-3.7 
(P 0.45) 
Mishra et al., 2013 
(9) 
RCT Low-fat vegan Meat diet -1.0 
(P 0.001) 
_ -0.7 
(P 0.004) 
-2.8 
(P 0.001) 
-7.2 
(P 0.001) 
Kahleova et al., 
2011 (6) 
RCT Vegan Conventional 
diabetic diet 
-1.03 
(P< 0.001) 
-0.44 
(P< 0.42) 
-0.66 
(P< 0.375) 
-3.0  
(P< 0.001) 
-0.54 
(P< 0.05) 
Wright et al., 2017 
(10) 
RCT Low-fat 
vegetarian 
Meat diet -3.9 
(P<0.0001) 
_ -1.5 
(P<0.0001) 
-10.6 
(P<0.0001) 
-7.2 
(P 0.12) 
